{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:35:36Z","timestamp":1793111736588,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Agence Nationale de la Recherche","award":["ANR-22-CE14-0052-0"],"award-info":[{"award-number":["ANR-22-CE14-0052-0"]}],"id":[{"id":"https:\/\/ror.org\/00rbzpz17","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["2 115797 945268"],"award-info":[{"award-number":["2 115797 945268"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cure One, Type 1 Diabetes Research Center the Dutch Diabetes fonds  Breakthrough T1D","award":["2-SRA-2024-1550-S-B"],"award-info":[{"award-number":["2-SRA-2024-1550-S-B"]}]},{"name":"Laboratoire d\u2019Excellence consortium Revive","award":["ANR-10-LABX-73-01"],"award-info":[{"award-number":["ANR-10-LABX-73-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00125-026-06839-7","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:07:49Z","timestamp":1787310469000},"page":"3440-3448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pancreatic islets: new discoveries for innovative treatments of diabetes?"],"prefix":"10.1007","volume":"69","author":[{"given":"Raphael","family":"Scharfmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Zaldumbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"7947","key":"6839_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/s0140-6736(75)92078-4","volume":"2","author":"L Orci","year":"1975","unstructured":"Orci L, Unger RH (1975) Functional subdivision of islets of Langerhans and possible role of D cells. Lancet 2(7947):1243\u20131244. https:\/\/doi.org\/10.1016\/s0140-6736(75)92078-4","journal-title":"Lancet"},{"issue":"9","key":"6839_CR2","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.2337\/db20-0304","volume":"69","author":"MP Dybala","year":"2020","unstructured":"Dybala MP, Butterfield JK, Hendren-Santiago BK, Hara M (2020) Pancreatic islets and gestalt principles. Diabetes 69(9):1864\u20131874. https:\/\/doi.org\/10.2337\/db20-0304","journal-title":"Diabetes"},{"issue":"9","key":"6839_CR3","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1369\/jhc.5C6684.2005","volume":"53","author":"M Brissova","year":"2005","unstructured":"Brissova M, Fowler MJ, Nicholson WE et al (2005) Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53(9):1087\u20131097. https:\/\/doi.org\/10.1369\/jhc.5C6684.2005","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"6839_CR4","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1073\/pnas.0510790103","volume":"103","author":"O Cabrera","year":"2006","unstructured":"Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103(7):2334\u20132339. https:\/\/doi.org\/10.1073\/pnas.0510790103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6839_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s001250050960","volume":"41","author":"L Bouwens","year":"1998","unstructured":"Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41(6):629\u2013633. https:\/\/doi.org\/10.1007\/s001250050960","journal-title":"Diabetologia"},{"issue":"1","key":"6839_CR6","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/s41467-024-47686-7","volume":"15","author":"J Lehrstrand","year":"2024","unstructured":"Lehrstrand J, Davies WIL, Hahn M, Korsgren O, Alanentalo T, Ahlgren U (2024) Illuminating the complete ss-cell mass of the human pancreas- signifying a new view on the islets of Langerhans. Nat Commun 15(1):3318. https:\/\/doi.org\/10.1038\/s41467-024-47686-7","journal-title":"Nat Commun"},{"issue":"1","key":"6839_CR7","doi-asserted-by":"publisher","first-page":"11379","DOI":"10.1038\/s41467-025-66198-6","volume":"16","author":"A Rippa","year":"2025","unstructured":"Rippa A, Posgai AL, Currlin S et al (2025) 3D imaging of human pancreas suggests islet size and endocrine composition influence their loss in type 1 diabetes. Nat Commun 16(1):11379. https:\/\/doi.org\/10.1038\/s41467-025-66198-6","journal-title":"Nat Commun"},{"issue":"46","key":"6839_CR8","doi-asserted-by":"publisher","first-page":"eadz2251","DOI":"10.1126\/sciadv.adz2251","volume":"11","author":"K Murrall","year":"2025","unstructured":"Murrall K, Luckett T, Lekka C et al (2025) Small things matter: lack of extraislet \u03b2 cells in type 1 diabetes. Sci Adv 11(46):eadz2251. https:\/\/doi.org\/10.1126\/sciadv.adz2251","journal-title":"Sci Adv"},{"issue":"9","key":"6839_CR9","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s42255-024-01114-8","volume":"6","author":"M Perez-Frances","year":"2024","unstructured":"Perez-Frances M, Bru-Tari E, Cohrs C et al (2024) Regulated and adaptive in vivo insulin secretion from islets only containing \u03b2-cells. Nat Metab 6(9):1791\u20131806. https:\/\/doi.org\/10.1038\/s42255-024-01114-8","journal-title":"Nat Metab"},{"key":"6839_CR10","doi-asserted-by":"publisher","first-page":"102245","DOI":"10.1016\/j.molmet.2025.102245","volume":"101","author":"A Fouque","year":"2025","unstructured":"Fouque A, Oshima M, Mode N et al (2025) Constructing chimeric mouse islets to study alpha- and delta-cell influence on beta-cell feature. Mol Metab 101:102245. https:\/\/doi.org\/10.1016\/j.molmet.2025.102245","journal-title":"Mol Metab"},{"issue":"10","key":"6839_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00125-020-05213-5","volume":"63","author":"MO Huising","year":"2020","unstructured":"Huising MO (2020) Paracrine regulation of insulin secretion. Diabetologia 63(10):2057\u20132063. https:\/\/doi.org\/10.1007\/s00125-020-05213-5","journal-title":"Diabetologia"},{"issue":"2","key":"6839_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","volume":"53","author":"M Cnop","year":"2010","unstructured":"Cnop M, Hughes SJ, Igoillo-Esteve M et al (2010) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53(2):321\u2013330. https:\/\/doi.org\/10.1007\/s00125-009-1562-x","journal-title":"Diabetologia"},{"issue":"10","key":"6839_CR13","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1210\/jc.2010-0932","volume":"95","author":"S Perl","year":"2010","unstructured":"Perl S, Kushner JA, Buchholz BA et al (2010) Significant human \u03b2-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 95(10):E234-239. https:\/\/doi.org\/10.1210\/jc.2010-0932","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6839_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/er.2007-0039","volume":"29","author":"D Scheuner","year":"2008","unstructured":"Scheuner D, Kaufman RJ (2008) The unfolded protein response: a pathway that links insulin demand with \u03b2-cell failure and diabetes. Endocr Rev 29(3):317\u2013333. https:\/\/doi.org\/10.1210\/er.2007-0039","journal-title":"Endocr Rev"},{"issue":"1","key":"6839_CR15","first-page":"55","volume":"40","author":"JH Nielsen","year":"1981","unstructured":"Nielsen JH (1981) Beta-cell function in isolated human pancreatic islets in long-term tissue culture. Acta Biol Med Ger 40(1):55\u201360","journal-title":"Acta Biol Med Ger"},{"issue":"6","key":"6839_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2337\/db08-1198","volume":"58","author":"MM Rankin","year":"2009","unstructured":"Rankin MM, Kushner JA (2009) Adaptive \u03b2-cell proliferation is severely restricted with advanced age. Diabetes 58(6):1365\u20131372. https:\/\/doi.org\/10.2337\/db08-1198","journal-title":"Diabetes"},{"issue":"6","key":"6839_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2337\/db08-1651","volume":"58","author":"SI Tschen","year":"2009","unstructured":"Tschen SI, Dhawan S, Gurlo T, Bhushan A (2009) Age-dependent decline in \u03b2-cell proliferation restricts the capacity of \u03b2-cell regeneration in mice. Diabetes 58(6):1312\u20131320. https:\/\/doi.org\/10.2337\/db08-1651","journal-title":"Diabetes"},{"issue":"9","key":"6839_CR18","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1172\/JCI129484","volume":"129","author":"R Scharfmann","year":"2019","unstructured":"Scharfmann R, Staels W, Albagli O (2019) The supply chain of human pancreatic \u03b2 cell lines. J Clin Invest 129(9):3511\u20133520. https:\/\/doi.org\/10.1172\/JCI129484","journal-title":"J Clin Invest"},{"issue":"3","key":"6839_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/db13-1013","volume":"63","author":"T Mezza","year":"2014","unstructured":"Mezza T, Muscogiuri G, Sorice GP et al (2014) Insulin resistance alters islet morphology in nondiabetic humans. Diabetes 63(3):994\u20131007. https:\/\/doi.org\/10.2337\/db13-1013","journal-title":"Diabetes"},{"issue":"9","key":"6839_CR20","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1074\/jbc.M115.683912","volume":"291","author":"K Robitaille","year":"2016","unstructured":"Robitaille K, Rourke JL, McBane JE et al (2016) High-throughput functional genomics identifies regulators of primary human beta cell proliferation. J Biol Chem 291(9):4614\u20134625. https:\/\/doi.org\/10.1074\/jbc.M115.683912","journal-title":"J Biol Chem"},{"issue":"4","key":"6839_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nm.3820","volume":"21","author":"P Wang","year":"2015","unstructured":"Wang P, Alvarez-Perez JC, Felsenfeld DP et al (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21(4):383\u2013388. https:\/\/doi.org\/10.1038\/nm.3820","journal-title":"Nat Med"},{"issue":"12","key":"6839_CR22","doi-asserted-by":"publisher","first-page":"101832","DOI":"10.1016\/j.xcrm.2024.101832","volume":"5","author":"E Karakose","year":"2024","unstructured":"Karakose E, Wang X, Wang P et al (2024) Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors. Cell Rep Med 5(12):101832. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101832","journal-title":"Cell Rep Med"},{"issue":"1\u20132","key":"6839_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2016.11.002","volume":"168","author":"N Ben-Othman","year":"2017","unstructured":"Ben-Othman N, Vieira A, Courtney M et al (2017) Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis. Cell 168(1\u20132):73-85 e11. https:\/\/doi.org\/10.1016\/j.cell.2016.11.002","journal-title":"Cell"},{"issue":"4","key":"6839_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2019.02.004","volume":"29","author":"M von Herrath","year":"2019","unstructured":"von Herrath M, Pagni PP, Grove K et al (2019) Case reports of pre-clinical replication studies in metabolism and diabetes. Cell Metab 29(4):795\u2013802. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.004","journal-title":"Cell Metab"},{"issue":"1","key":"6839_CR25","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.1038\/s41598-025-95751-y","volume":"15","author":"H Hill","year":"2025","unstructured":"Hill H, Lundkvist P, Tsatsaris G, Birnir B, Espes D, Carlsson PO (2025) Long-term gamma-aminobutyric acid (GABA) treatment fails to regain beta-cell function in longstanding type 1 diabetes in a randomized trial. Sci Rep 15(1):11530. https:\/\/doi.org\/10.1038\/s41598-025-95751-y","journal-title":"Sci Rep"},{"issue":"5","key":"6839_CR26","doi-asserted-by":"publisher","first-page":"102126","DOI":"10.1016\/j.xcrm.2025.102126","volume":"6","author":"S Silvano","year":"2025","unstructured":"Silvano S, Napolitano T, Plaisant M et al (2025) RSPO1, a potent inducer of pancreatic \u03b2 cell neogenesis. Cell Rep Med 6(5):102126. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102126","journal-title":"Cell Rep Med"},{"issue":"10","key":"6839_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-8587(21)00170-4","volume":"9","author":"NAJ Krentz","year":"2021","unstructured":"Krentz NAJ, Shea LD, Huising MO, Shaw JAM (2021) Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering. Lancet Diabetes Endocrinol 9(10):708\u2013724. https:\/\/doi.org\/10.1016\/S2213-8587(21)00170-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"6839_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.125.6.1017","volume":"125","author":"F Miralles","year":"1998","unstructured":"Miralles F, Czernichow P, Scharfmann R (1998) Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 125(6):1017\u20131024. https:\/\/doi.org\/10.1242\/dev.125.6.1017","journal-title":"Development"},{"key":"6839_CR29","unstructured":"Thivolet C, Chatelain P, Haftek M, Durand A, Pugeat M (1986) Morphologic and functional study of a human insulin-secreting cell line. C R Acad Sci III 303(10): 381\u2013386 [article in French]"},{"issue":"6","key":"6839_CR30","first-page":"3410","volume":"27","author":"F Levine","year":"1995","unstructured":"Levine F, Wang S, Beattie GM et al (1995) Development of a cell line from the human fetal pancreas. Transplant Proc 27(6):3410","journal-title":"Transplant Proc"},{"issue":"4728","key":"6839_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1126\/science.3904002","volume":"230","author":"T Edlund","year":"1985","unstructured":"Edlund T, Walker MD, Barr PJ, Rutter WJ (1985) Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5\u2019 flanking elements. Science 230(4728):912\u2013916. https:\/\/doi.org\/10.1126\/science.3904002","journal-title":"Science"},{"issue":"11","key":"6839_CR32","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1007\/s001250100012","volume":"44","author":"M Castaing","year":"2001","unstructured":"Castaing M, Peault B, Basmaciogullari A, Casal I, Czernichow P, Scharfmann R (2001) Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44(11):2066\u20132076. https:\/\/doi.org\/10.1007\/s001250100012","journal-title":"Diabetologia"},{"issue":"10","key":"6839_CR33","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/nbt1145","volume":"23","author":"M Narushima","year":"2005","unstructured":"Narushima M, Kobayashi N, Okitsu T et al (2005) A human \u03b2-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23(10):1274\u20131282. https:\/\/doi.org\/10.1038\/nbt1145","journal-title":"Nat Biotechnol"},{"issue":"9","key":"6839_CR34","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1172\/JCI58447","volume":"121","author":"P Ravassard","year":"2011","unstructured":"Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121(9):3589\u20133597. https:\/\/doi.org\/10.1172\/JCI58447","journal-title":"J Clin Invest"},{"key":"6839_CR35","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.molmet.2023.101772","volume":"76","author":"B Blanchi","year":"2023","unstructured":"Blanchi B, Taurand M, Colace C et al (2023) EndoC-\u03b2H5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol Metab 76:101772. https:\/\/doi.org\/10.1016\/j.molmet.2023.101772","journal-title":"Mol Metab"},{"issue":"6776","key":"6839_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.adx3736","volume":"390","author":"E Scharfmann","year":"2025","unstructured":"Scharfmann E, Marx M, Fleming L (2025) Pasteur\u2019s quadrant researchers bring novelty, impact to publishing, and patenting. Science 390(6776):891\u2013893. https:\/\/doi.org\/10.1126\/science.adx3736","journal-title":"Science"},{"issue":"4","key":"6839_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00125-013-3155-y","volume":"57","author":"L Krogvold","year":"2014","unstructured":"Krogvold L, Edwin B, Buanes T et al (2014) Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 57(4):841\u2013843. https:\/\/doi.org\/10.1007\/s00125-013-3155-y","journal-title":"Diabetologia"},{"issue":"1","key":"6839_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dom.12544","volume":"18","author":"D Laurent","year":"2016","unstructured":"Laurent D, Vinet L, Lamprianou S et al (2016) Pancreatic \u03b2-cell imaging in humans: fiction or option? Diabetes Obes Metab 18(1):6\u201315. https:\/\/doi.org\/10.1111\/dom.12544","journal-title":"Diabetes Obes Metab"},{"issue":"19","key":"6839_CR39","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.3390\/ijms21197274","volume":"21","author":"S Demine","year":"2020","unstructured":"Demine S, Schulte ML, Territo PR, Eizirik DL (2020) Beta cell imaging-from pre-clinical validation to first in man testing. Int J Mol Sci 21(19):7274. https:\/\/doi.org\/10.3390\/ijms21197274","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6839_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2337\/db22-0884","volume":"72","author":"TJP Jansen","year":"2023","unstructured":"Jansen TJP, Buitinga M, Boss M et al (2023) Monitoring \u03b2-cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-concept study in individuals with type 1 diabetes. Diabetes 72(7):898\u2013907. https:\/\/doi.org\/10.2337\/db22-0884","journal-title":"Diabetes"},{"issue":"10","key":"6839_CR41","doi-asserted-by":"publisher","first-page":"eaat3386","DOI":"10.1126\/sciadv.aat3386","volume":"4","author":"C Ammala","year":"2018","unstructured":"Ammala C, Drury WJ 3rd, Knerr L et al (2018) Targeted delivery of antisense oligonucleotides to pancreatic \u03b2-cells. Sci Adv 4(10):eaat3386. https:\/\/doi.org\/10.1126\/sciadv.aat3386","journal-title":"Sci Adv"},{"issue":"1","key":"6839_CR42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41467-022-29377-3","volume":"13","author":"D Van Simaeys","year":"2022","unstructured":"Van Simaeys D, De La Fuente A, Zilio S et al (2022) RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human \u03b2 cells. Nat Commun 13(1):1815. https:\/\/doi.org\/10.1038\/s41467-022-29377-3","journal-title":"Nat Commun"},{"issue":"14","key":"6839_CR43","doi-asserted-by":"publisher","first-page":"e136579","DOI":"10.1172\/jci.insight.136579","volume":"5","author":"D Neiman","year":"2020","unstructured":"Neiman D, Gillis D, Piyanzin S et al (2020) Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic \u03b2 cells. JCI Insight 5(14):e136579. https:\/\/doi.org\/10.1172\/jci.insight.136579","journal-title":"JCI Insight"},{"issue":"8","key":"6839_CR44","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1097\/TP.0000000000000625","volume":"99","author":"MA Kanak","year":"2015","unstructured":"Kanak MA, Takita M, Shahbazov R et al (2015) Evaluation of microRNA375 as a novel biomarker for graft damage in clinical islet transplantation. Transplantation 99(8):1568\u20131573. https:\/\/doi.org\/10.1097\/TP.0000000000000625","journal-title":"Transplantation"},{"issue":"8","key":"6839_CR45","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41422-021-00489-7","volume":"31","author":"W Staels","year":"2021","unstructured":"Staels W, Scharfmann R (2021) Pancreatic endocrinogenesis revisited: \u201cI have all the answers, who has the questions?\u201d Cell Res 31(8):834\u2013835. https:\/\/doi.org\/10.1038\/s41422-021-00489-7","journal-title":"Cell Res"},{"issue":"7","key":"6839_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","volume":"19","author":"DL Eizirik","year":"2023","unstructured":"Eizirik DL, Szymczak F, Mallone R (2023) Why does the immune system destroy pancreatic \u03b2-cells but not \u03b1-cells in type 1 diabetes? Nat Rev Endocrinol 19(7):425\u2013434. https:\/\/doi.org\/10.1038\/s41574-023-00826-3","journal-title":"Nat Rev Endocrinol"},{"issue":"7746","key":"6839_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-019-0942-8","volume":"567","author":"K Furuyama","year":"2019","unstructured":"Furuyama K, Chera S, van Gurp L et al (2019) Diabetes relief in mice by glucose-sensing insulin-secreting human \u03b1-cells. Nature 567(7746):43\u201348. https:\/\/doi.org\/10.1038\/s41586-019-0942-8","journal-title":"Nature"},{"issue":"4","key":"6839_CR48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","volume":"24","author":"A Segerstolpe","year":"2016","unstructured":"Segerstolpe A, Palasantza A, Eliasson P et al (2016) Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab 24(4):593\u2013607. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.020","journal-title":"Cell Metab"},{"issue":"7039","key":"6839_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature03625","volume":"435","author":"SC Kent","year":"2005","unstructured":"Kent SC, Chen Y, Bregoli L et al (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435(7039):224\u2013228. https:\/\/doi.org\/10.1038\/nature03625","journal-title":"Nature"},{"issue":"7039","key":"6839_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature03523","volume":"435","author":"M Nakayama","year":"2005","unstructured":"Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435(7039):220\u2013223. https:\/\/doi.org\/10.1038\/nature03523","journal-title":"Nature"},{"issue":"4","key":"6839_CR51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm.4289","volume":"23","author":"MJ Kracht","year":"2017","unstructured":"Kracht MJ, van Lummel M, Nikolic T et al (2017) Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat Med 23(4):501\u2013507. https:\/\/doi.org\/10.1038\/nm.4289","journal-title":"Nat Med"},{"key":"6839_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coi.2016.09.007","volume":"43","author":"BO Roep","year":"2016","unstructured":"Roep BO, Kracht MJ, van Lummel M, Zaldumbide A (2016) A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes. Curr Opin Immunol 43:67\u201373. https:\/\/doi.org\/10.1016\/j.coi.2016.09.007","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"6839_CR53","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.2337\/db20-0013","volume":"69","author":"ME Azoury","year":"2020","unstructured":"Azoury ME, Tarayrah M, Afonso G et al (2020) Peptides derived from insulin granule proteins are targeted by CD8+ T cells across MHC class I restrictions in humans and NOD mice. Diabetes 69(12):2678\u20132690. https:\/\/doi.org\/10.2337\/db20-0013","journal-title":"Diabetes"},{"issue":"6","key":"6839_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diab.39.6.697","volume":"39","author":"K Aaen","year":"1990","unstructured":"Aaen K, Rygaard J, Josefsen K et al (1990) Dependence of antigen expression on functional state of \u03b2-cells. Diabetes 39(6):697\u2013701. https:\/\/doi.org\/10.2337\/diab.39.6.697","journal-title":"Diabetes"},{"issue":"9","key":"6839_CR55","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00125-022-05722-5","volume":"65","author":"I Zucker","year":"2022","unstructured":"Zucker I, Zloof Y, Bardugo A et al (2022) Obesity in late adolescence and incident type 1 diabetes in young adulthood. Diabetologia 65(9):1473\u20131482. https:\/\/doi.org\/10.1007\/s00125-022-05722-5","journal-title":"Diabetologia"},{"key":"6839_CR56","doi-asserted-by":"publisher","first-page":"1032822","DOI":"10.3389\/fendo.2022.1032822","volume":"13","author":"K Josefsen","year":"2022","unstructured":"Josefsen K, Krogvold L, Gerling IC, Pociot F, Dahl-Jorgensen K, Buschard K (2022) Development of type 1 diabetes may occur through a type 2 diabetes mechanism. Front Endocrinol (Lausanne) 13:1032822. https:\/\/doi.org\/10.3389\/fendo.2022.1032822","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"6839_CR57","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1210\/en.2004-1378","volume":"146","author":"AH Minn","year":"2005","unstructured":"Minn AH, Hafele C, Shalev A (2005) Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces \u03b2-cell apoptosis. Endocrinology 146(5):2397\u20132405. https:\/\/doi.org\/10.1210\/en.2004-1378","journal-title":"Endocrinology"},{"issue":"4","key":"6839_CR58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2337\/db11-0955","volume":"61","author":"G Xu","year":"2012","unstructured":"Xu G, Chen J, Jing G, Shalev A (2012) Preventing \u03b2-cell loss and diabetes with calcium channel blockers. Diabetes 61(4):848\u2013856. https:\/\/doi.org\/10.2337\/db11-0955","journal-title":"Diabetes"},{"issue":"8","key":"6839_CR59","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","volume":"24","author":"F Ovalle","year":"2018","unstructured":"Ovalle F, Grimes T, Xu G et al (2018) Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med 24(8):1108\u20131112. https:\/\/doi.org\/10.1038\/s41591-018-0089-4","journal-title":"Nat Med"},{"issue":"3","key":"6839_CR60","doi-asserted-by":"publisher","first-page":"a007724","DOI":"10.1101\/cshperspect.a007724","volume":"2","author":"JI Odegaard","year":"2012","unstructured":"Odegaard JI, Chawla A (2012) Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med 2(3):a007724. https:\/\/doi.org\/10.1101\/cshperspect.a007724","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"6839_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Pasquali L, Cnop M (2020) Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol 16(7):349\u2013362. https:\/\/doi.org\/10.1038\/s41574-020-0355-7","journal-title":"Nat Rev Endocrinol"},{"key":"6839_CR62","doi-asserted-by":"publisher","first-page":"1520313","DOI":"10.3389\/fendo.2024.1520313","volume":"15","author":"O Resnick","year":"2024","unstructured":"Resnick O, Bril F, Beauchamp G (2024) Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer? Front Endocrinol (Lausanne) 15:1520313. https:\/\/doi.org\/10.3389\/fendo.2024.1520313","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"6839_CR63","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/s41591-025-03723-6","volume":"31","author":"FH Mahmud","year":"2025","unstructured":"Mahmud FH, Bjornstad P, Clarson C et al (2025) Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Nat Med 31(7):2317\u20132324. https:\/\/doi.org\/10.1038\/s41591-025-03723-6","journal-title":"Nat Med"},{"issue":"21","key":"6839_CR64","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.3390\/nu17213349","volume":"17","author":"BM Sperkowska","year":"2025","unstructured":"Sperkowska BM, Chrustek A, Gryn-Rynko A, Proszowska A (2025) Dietary interventions for adults with type 1 diabetes: clinical outcomes, guideline alignment, and research gaps-A scoping review. Nutrients 17(21):3349. https:\/\/doi.org\/10.3390\/nu17213349","journal-title":"Nutrients"},{"issue":"5","key":"6839_CR65","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","volume":"25","author":"B Svendsen","year":"2018","unstructured":"Svendsen B, Larsen O, Gabe MBN et al (2018) Insulin secretion depends on intra-islet glucagon signaling. Cell Rep 25(5):1127-1134 e1122. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.018","journal-title":"Cell Rep"},{"issue":"2","key":"6839_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/diab.25.2.136","volume":"25","author":"RH Unger","year":"1976","unstructured":"Unger RH (1976) The banting memorial lecture 1975. Diabetes and the alpha cell. Diabetes 25(2):136\u2013151. https:\/\/doi.org\/10.2337\/diab.25.2.136","journal-title":"Diabetes"},{"issue":"10","key":"6839_CR67","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.celrep.2018.02.032","volume":"22","author":"M Brissova","year":"2018","unstructured":"Brissova M, Haliyur R, Saunders D et al (2018) \u03b1 cell function and gene expression are compromised in type 1 diabetes. Cell Rep 22(10):2667\u20132676. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.032","journal-title":"Cell Rep"},{"issue":"23","key":"6839_CR68","doi-asserted-by":"publisher","first-page":"e195267","DOI":"10.1172\/JCI195267","volume":"135","author":"T Dos Santos","year":"2025","unstructured":"Dos Santos T, Dai XQ, Jones RC et al (2025) Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes. J Clin Invest 135(23):e195267. https:\/\/doi.org\/10.1172\/JCI195267","journal-title":"J Clin Invest"},{"issue":"11","key":"6839_CR69","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.2337\/db10-0728","volume":"59","author":"BA Cooperberg","year":"2010","unstructured":"Cooperberg BA, Cryer PE (2010) Insulin reciprocally regulates glucagon secretion in humans. Diabetes 59(11):2936\u20132940. https:\/\/doi.org\/10.2337\/db10-0728","journal-title":"Diabetes"},{"issue":"3","key":"6839_CR70","doi-asserted-by":"publisher","first-page":"e13464","DOI":"10.1111\/apha.13464","volume":"229","author":"SFS Xu","year":"2020","unstructured":"Xu SFS, Andersen DB, Izarzugaza JMG, Kuhre RE, Holst JJ (2020) In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose-induced inhibition of glucagon secretion. Acta Physiol (Oxf) 229(3):e13464. https:\/\/doi.org\/10.1111\/apha.13464","journal-title":"Acta Physiol (Oxf)"},{"issue":"11","key":"6839_CR71","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17(11):1481\u20131489. https:\/\/doi.org\/10.1038\/nm.2513","journal-title":"Nat Med"},{"issue":"38","key":"6839_CR72","doi-asserted-by":"publisher","first-page":"eady8048","DOI":"10.1126\/sciadv.ady8048","volume":"11","author":"C Cui","year":"2025","unstructured":"Cui C, Leander DC, Gray SM et al (2025) \u03b1 cells use both PC1\/3 and PC2 to process proglucagon peptides and control insulin secretion. Sci Adv 11(38):eady8048. https:\/\/doi.org\/10.1126\/sciadv.ady8048","journal-title":"Sci Adv"},{"key":"6839_CR73","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.molmet.2020.101014","volume":"39","author":"SA Campbell","year":"2020","unstructured":"Campbell SA, Golec DP, Hubert M et al (2020) Human islets contain a subpopulation of glucagon-like peptide-1 secreting \u03b1 cells that is increased in type 2 diabetes. Mol Metab 39:101014. https:\/\/doi.org\/10.1016\/j.molmet.2020.101014","journal-title":"Mol Metab"},{"issue":"1","key":"6839_CR74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2337\/diab.47.1.66","volume":"47","author":"K Moens","year":"1998","unstructured":"Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F (1998) Dual glucagon recognition by pancreatic \u03b2-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 47(1):66\u201372. https:\/\/doi.org\/10.2337\/diab.47.1.66","journal-title":"Diabetes"},{"issue":"19","key":"6839_CR75","doi-asserted-by":"publisher","first-page":"20345","DOI":"10.1074\/jbc.M312483200","volume":"279","author":"S Dalle","year":"2004","unstructured":"Dalle S, Longuet C, Costes S et al (2004) Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK1\/2 in MIN6 cell line and isolated islets of Langerhans. J Biol Chem 279(19):20345\u201320355. https:\/\/doi.org\/10.1074\/jbc.M312483200","journal-title":"J Biol Chem"},{"issue":"18","key":"6839_CR76","doi-asserted-by":"publisher","first-page":"10102","DOI":"10.1073\/pnas.131200398","volume":"98","author":"Y Jiang","year":"2001","unstructured":"Jiang Y, Cypess AM, Muse ED et al (2001) Glucagon receptor activates extracellular signal-regulated protein kinase 1\/2 via cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 98(18):10102\u201310107. https:\/\/doi.org\/10.1073\/pnas.131200398","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6839_CR77","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.stem.2025.07.006","volume":"32","author":"G Meng","year":"2025","unstructured":"Meng G, Gu J, Liew SY et al (2025) Reconstruction of endocrine subtype-complete human pluripotent stem cell-derived islets with capacity for hypoglycemia protection in vivo. Cell Stem Cell 32(9):1438-1456 e1437. https:\/\/doi.org\/10.1016\/j.stem.2025.07.006","journal-title":"Cell Stem Cell"},{"issue":"22","key":"6839_CR78","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","volume":"187","author":"S Wang","year":"2024","unstructured":"Wang S, Du Y, Zhang B et al (2024) Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 187(22):6152-6164 e6118. https:\/\/doi.org\/10.1016\/j.cell.2024.09.004","journal-title":"Cell"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06839-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06839-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06839-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:53:27Z","timestamp":1793109207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06839-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["6839"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06839-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank M. Solimena (Paul Langerhans Institute Dresden, Germany) and S. J. Richardson (Exeter Centre of Excellence for Diabetes Research, UK) for discussions and D. N. Tran (Leiden University Medical Center, the Netherlands) for careful reading and editing of the manuscript.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Work in the authors\u2019 laboratories is supported by funding from the Agence Nationale de la Recherche (ANR-22-CE14-0052-01) (RS), the Laboratoire d\u2019Excellence consortium Revive (Investissements d\u2019Avenir ANR-10-LABX-73-01) (RS), Cure One, Type 1 Diabetes Research Center (AZ), the Dutch Diabetes fonds (AZ), Breakthrough T1D (grant 2-SRA-2024-1550-S-B) (AZ), the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements 115797 and 945268 (INNODIA HARVEST), which receive support from the EU Horizon 2020 programme, Breakthrough T1D (formerly known as JDRF) and The Leona M. & Harry B. Helmsley Charitable Trust (RS and AZ).","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"RS is a shareholder and consultant for Human Cell Design. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"RS and AZ were responsible for drafting the article and reviewing it critically for important intellectual content. They both approved the version to be published.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}